Robert E. Landry

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Zymeworks Inc. publishes a filing, an earnings call transcript or a press release.

Get ZYME alerts

About Robert E. Landry

Robert E. Landry is recorded as Board Member at Zymeworks Inc. (ZYME) since August 10, 2025. Zymeworks Inc. reported in an 8-K filed August 11, 2025 that Robert E. Landry was appointed director of the Company, effective August 10, 2025. Zymeworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zymeworks Inc. includes Ali Tehrani (CEO), Kenneth Galbraith (CEO and CFO), Kristin Stafford (CFO) and 7 others.

“On August 10, 2025, the board of directors (the "Board") of Zymeworks Inc. (the "Company"), upon recommendation from the nominating and corporate governance committee of the Board (the "Nominating Committee"), appointed Messrs. Gregory A. Ciongoli and Robert E. Landry as directors of the Company, effective as of August 10, 2025.”

Zymeworks Inc. Form 8-K, filed August 11, 2025 · Read the filing

Affiliation history

Zymeworks Inc. (ZYME)
Board Member

SEC 8-K

Current
2025-08-10–present

Company network

Zymeworks Inc.

ZYME

Current role

Biotechnology · Healthcare

Board Member

2025-08-10–present

Leadership on record at Zymeworks Inc.

Ali Tehrani CEO
Kenneth Galbraith CEO, CFO
Kristin Stafford CFO
Leone Patterson CFO
Mark Hollywood COO
Scott Platshon CIO, Board Member
Paul Schneider General Counsel
Alessandra Cesano Board Member
Brian Cherry Board Member
Carlos Campoy Board Member

Recent activity

Executive change Appointed: director of the Company Zymeworks Inc. (ZYME)
2025-08-10